Skip to main content
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Main navigation - Mobile
Bringing Real World Evidence into Clinical Research
Pharma has a real-world problem: sensor adoption
Monday, May 7, 2018
If you've been following pharma's “smart inhaler” deals, you might think the industry's up to speed on sensor tech—but you'd be wrong.
Amgen rolls out real-world Repatha data backing a $10K price
Wednesday, August 23, 2017
With real-world cardiovascular outcomes, Amgen says Repatha is cost-effective at $9,669 per year.
GSK's Breo aims for a real-world data boost
Tuesday, May 9, 2017
A year after showing its Breo Ellipta could cut down on COPD exacerbations, new data says GSK's med trumps usual care at controlling asthma, too.
AAN rundown, with dueling MS data, new candidates and more
Wednesday, April 26, 2017
Some closely watched new drugs grabbed the spotlight at the American Academy of Neurology meeting this week, and plenty of other therapies put up results worth noting.
Glaxo malaria shot set for WHO pilot test in Africa
Monday, April 24, 2017
WHO plans real-world pilot studies of GlaxoSmithKline’s malaria jab Mosquirix in three African countries.
Eliquis smashes rivals at bleed-related costs: study
Saturday, March 18, 2017
Only one of the three leading next-gen anticoagulants showed it could save the healthcare system hundreds of dollars per patient in a new real-world study.
Biogen aims real-world data at Tecfidera's patient drop-out problem
Monday, September 19, 2016
Biogen’s MS drug Tecfidera has a problem: A relatively high number of patients start the drug, only to stop taking it later. Now, the company is touting some real-world data that could help.